Evidence map›Paper›PMID 21139582›Full record

ArticleBritish journal of cancer2011

The HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42.

A W Oliver, X He, K Borthwick, A J Donne, L Hampson, I N Hampson

Abstract read
In one paragraph

Article in British journal of cancer, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Double inhibition and activation mechanisms of Ephexin family RhoGEFs.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A W OliverUniversity of Manchester Gynaecological Oncology Laboratories, School of Cancer and Enabling Sciences, St Mary's Hospital, Oxford Road, Manchester M13 9WL, UK.
X He
K Borthwick
A J Donne
L Hampson
I N Hampson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGuanidine exchange factor (GEF)-catalysed activation of Rho proteins such as Cdc42 has been shown to have a crucial role in cellular transformation, malignant progression and invasion. We have previously shown that the HPV16 E6 oncoprotein binds to the PDZ domain protein Tax-interacting-protein 1 (Tip-1) and we now report identification and functional analysis of a novel Tip-1 binding GEF.

methodsYeast two-hybrid, in vitro pull-down, site-directed mutagenesis, semiquantitative PCR, co-immunoprecipitation and western blotting were used to identify/confirm novel Tip-1 binding partners and analyse cellular expression levels. In vitro kinetic analyses of recombinant proteins, siRNA gene silencing and in cell assays were used to measure Rho protein activation.

resultsTax-interacting-protein 1 was shown to interact with ARHGEF16 by its carboxyl PDZ binding motif. Levels of ARHGEF16 were increased in transformed and immortalised cells expressing ectopic HPV16 E6 and Cdc42 was co-immunoprecipitated by ARHGEF16 in the presence of high-risk HPV E6. In vitro kinetic analysis confirmed that recombinant ARHGEF16 activates Cdc42 and this was increased by the addition of recombinant Tip-1 and E6. Cells expressing HPV16 E6 had higher levels of Cdc42 activation, which was decreased by siRNA silencing of either Tip-1 or ARHGEF16.

conclusionThese data suggest that HPV16 E6, Tip-1 and ARHGEF16 may cooperate to activate Cdc42 and support a potential link between the expression of HPV16 E6 and Cdc42 activation.

Indexed as

Base SequenceBlotting, Westerncdc42 GTP-Binding ProteinDNA PrimersGene SilencingGuanine Nucleotide Exchange FactorsIntracellular Signaling Peptides and ProteinsMutagenesis, Site-DirectedOncogene Proteins, ViralPolymerase Chain ReactionProtein BindingRepressor ProteinsReverse Transcriptase Polymerase Chain ReactionRNA, Small InterferingTwo-Hybrid System TechniquesARHGEF16 protein, humancdc42 GTP-Binding ProteinDNA PrimersE6 protein, Human papillomavirus type 16Guanine Nucleotide Exchange FactorsIntracellular Signaling Peptides and ProteinsOncogene Proteins, ViralRepressor ProteinsRNA, Small InterferingTAX1BP3 protein, human

Identifiers

PMID21139582
PMCPMC3031889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.